我院2007～2014年抗病毒药物应用分析  

Application analysis of antiviral drug in our hospital during 2007-2014

作　　者：吕小丹[1] 

机构地区：[1]济南市传染病医院药剂科,250021

出　　处：《中国现代药物应用》2016年第13期22-23,共2页Chinese Journal of Modern Drug Application

摘　　要：目的 评价济南市传染病医院（以下简称“本院”）2007~2014年抗病毒药物使用情况。方法 对本院2007~2014年抗病毒药物的使用金额和用药频度（DDDs）进行统计和分析。结果 2007~2014年抗病毒药物的使用金额呈上升趋势,抗病毒药物金额构成比亦呈上升趋势;恩替卡韦目前已取代阿德福韦酯成为使用最广泛的抗病毒药物,2013年恩替卡韦用药金额已上升至排名第一。结论 核苷类药物在抗病毒药物临床使用中占绝对优势,应有效干预抗病毒药物的临床使用,避免耐药和不良反应的发生。Objective To evaluate application condition of antiviral drug in Jinan infectious diseases hospital （our hospital） during 2007-2014. Methods Summary and analysis was made on using amount and defined daily doses （DDDs） of antiviral drug during 2007-2014 in our hospital. Results With increasing using amount of antivirat drug year by year, constituent ratio of antiviral drug cost als0 showed an increasing trend during 2007-.2014. As the most popular antiviral drug, entecavir took the former place of adefovir dipivoxil. Medication amount of entecavir increased to the first place in 2013. Conclusion Nucleoside drug contains absolute advantage in clinical application of antiviral drug. Effective intervention on clinical application of antiviral drug is necessary to avoid drug resistance and adverse reactions.

关 键 词：抗病毒药物 用药频度 药物分析 

分 类 号：R978.7[医药卫生—药品]